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ABSTRACT Two major characteristics of baculovirus in-
fection are arrest of the host cell at G2yM phase of the cell
cycle with continuing viral DNA replication. We show that
Autographa californica nucleopolyhedrovirus (AcMNPV) en-
codes for a multifunctional cyclin that may partially explain
the molecular basis of these important characteristics of
AcMNPV (baculovirus) infection. Amino acids 80–110 of the
viral structural protein ODV-EC27 (2EC27) demonstrate
25–30% similarity with cellular cyclins within the cyclin box.
Immunoprecipitation results using antibodies to 2EC27 show
that 2EC27 can associate with either cdc2 or cdk6 resulting
in active kinase complexes that can phosphorylate histone H1
and retinoblastoma protein in vitro. The cdk6-EC27 complex
also associates with proliferating cell nuclear antigen (PCNA)
and we demonstrate that PCNA is a structural protein of both
the budded virus and the occlusion-derived virus. These
results suggest that 2EC27 can function as a multifunctional
cyclin: when associated with cdc2, it exhibits cyclin B-like
activity; when associated with cdk6, the complex possesses
cyclin D-like activity and binds PCNA. The possible roles of
such a multifunctional cyclin during the life cycle of baculo-
virus are discussed, along with potential implications relative
to the expression of functionally authentic recombinant pro-
teins by using baculovirus-infected cells.
Autographa californica nucleopolyhedrovirus (AcMNPV) in-
fection produces two types of viral progeny. The occlusion-
derived viral form (ODV) is optimal for infection of the insect
gut, and therefore transmits infection from insect to insect in
nature. The budded virus form (BV) transmits infection from
cell to cell during secondary infection. ODV infects gut cells
by fusion of the viral envelope with the columnar cell microvil-
lar membranes, whereas BV entry of other cells occurs by
adsorptive endocytosis. After viral uptake, the nucleocapsid
induces actin polymerization (in vitro) that suggests that actin
cables may be involved in the movement of nucleocapsids to
the nucleus where uncoating occurs (1). ODV and BV differ
significantly in their ability to infect the insect through the gut
and, viral envelopes and nucleocapsids of the two viral forms
contain different proteins, or proteins that are processed
differently (2).
Our studies emphasize investigation of the process of ODV
envelope maturation that occurs by the abundant proliferation
of intranuclear membranes that serve as precursor membranes
for ODV envelopes. We note similarities between the pheno-
type of enlarged nuclei, intranuclear membrane proliferation,
and nuclear envelopment during baculovirus infection and the
early stages of mitosis in insects (3). In some insect cells, the
nuclear envelope may be a source of intranuclear membranes,
including small vesicles and an envelope of the spindle appa-
ratus (4–6). However, in AcMNPV-infected cells, the nuclear
envelope remains largely intact, with small regional perturba-
tions. Our data support the hypothesis that proliferation of the
inner nuclear membrane or nuclear envelope produces the
intranuclear membranes essential for ODV nucleocapsid en-
velopment.
In higher eukaryotes, the entry into mitosis is controlled by
activation of the cyclin B-cdc2 complex that results in phos-
phorylation and disorganization of the nuclear lamina, and
increased nuclear envelope fluidity (7–10). By mid-metaphase,
the cyclin B-cdc2 complex is inactivated by ubiquinitation and
proteolysis of the cyclin B subunit. This allows nuclear enve-
lope dispersal as well as exit from mitosis (9, 11). When cells
are transfected with a nondestructible analog of cyclin B,
progression through the cell cycle is arrested at M phase with
an enlarged nucleus and an intact nuclear envelope (8, 10, 12).
We show that AcMNPV infection of Sf9 cells results in host cell
cycle arrest at G2yM phase with an intact nuclear envelope,
concomitant with sustained cdc2-associated histone H1 kinase
activity even after degradation of cellular cyclin B. This data
suggests a model where host cell cycle arrest is maintained by
an active, viral-encoded nondegradable analog of cyclin B-
cdc2 complex. We also note that baculovirus DNA replication
still occurs in G2yM phase-arrested cells (3). Thus, during
infection, the virus must encode some mechanism to override
cellular checkpoints and maintain an ‘‘S phase-like’’ environ-
ment conducive for viral DNA replication in G2yM phase-
arrested cells.
We now report that AcMNPV encodes a protein (ODV-
EC27; 2EC27) capable of acting as a multifunctional cyclin.
This protein is detected in purified ODV; however, potentially
modified forms of this protein are also present in BV (13).
2EC27 is present in complexes containing either cdc2 or cdk6
and these complexes can phosphorylate both histone H1 and
retinoblastoma protein (pRb) in vitro. Proliferating cell nu-
clear antigen (PCNA) can also associate with the cdk6-EC27
complex. Additionally, we show that 2EC27 and PCNA are
both structural proteins of ODV and that PCNA is also present
in purified BV. The potential role and function of 2EC27
acting like B-type andyor D-type cyclin during the baculovirus
life cycle are considered.
MATERIALS AND METHODS
Insect Cell Lines and Virus Spodoptera frugiperda IPLB-
Sf21-AE clonal isolate 9 (Sf9) cells were cultured in suspension
at 27°C in TNMFH medium supplemented with 10% fetal
bovine serum. Cells were maintained and infected in log phase
growth and cell density was '1.2–1.5 3 106 cellsyml at the time
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of infection. Cells were infected at a multiplicity of infection of
20 by using the baculovirus AcMNPV (E2 strain).
Immunoprecipitation and in Vitro Kinase Assays. Immuno-
precipitation with antisera to 2EC27 and subsequent kinase
assays were performed as described (3, 14). Briefly, Sf9 cells
were infected, time course samples were collected and then
analyzed for protein content (15). Whole-cell lysate (150 mg
total protein) from each sample was dissolved in RIPA buffer
50 mM Trisy150 mM NaCly0.5% Triton X-100y0.5% deoxy-
cholate, pH 7.5, containing protease and phosphatase inhib-
itors, precleared by incubating with protein AyG agarose beads
and immunoprecipitated with 10 ml of antiserum to 2EC27
(no. 7351). Immune complexes were collected on protein AyG
agarose beads; washed three times with RIPA buffer and three
times in kinase assay buffer (50 mM Trisy10 mM MgCl2y1 mM
DTT, pH 7.5). Kinase reactions were initiated by resuspending
the 2EC27 immunoprecipitate in 20 ml of a reaction mixture
consisting of kinase assay buffer (30°C) containing 1 mg
histone H1 protein (Boehringer Mannheim) or 500 ng of pRb
(Santa Cruz Biotechnology) and 100 mM ATP and 50 mCi of
g-32P-ATP (3,000 Ciymmol;1 Ci 5 37 GBq). Reactions pro-
ceeded for 30 min (30°C) and were terminated by addition of
10 ml of 43 SDS sample buffer. The mixture was boiled for 3
min, centrifuged at 16,000 3 g (3 min) and the entire sample
loaded onto a 15% SDSyPAGE gel. Phosphorylated histone
H1 and pRb bands were quantified by PhosphorImager SF
(Molecular Dynamics). To confirm equal loading of samples,
the gels were stained with Coomassie blue.
Lysates were depleted for individual cdks by three consec-
utive treatments with 20 mg of antibody specific for the cdk. All
antibodies were rabbit polyclonal antibodies (Santa Cruz
Biotechnology) and were shown to cross-react with insect cdks
(data not shown). Depleted lysates were subsequently treated
with antiserum to 2EC27 (as above), and the immunoprecipi-
tated samples were assayed for kinase activity by using histone
H1 or pRb as substrates.
Western Blot Analysis. Proteins were separated by using
SDSyPAGE (16) and transferred to poly(vinylidene difluo-
ride) membranes by using Western blot techniques (17). The
membranes were blocked with tris buffered saline (0.5%
Tween 20; 1% dry milk) and primary antibody bound over-
night (4°C). Blots were washed and horseradish peroxidase-
linked IgG (1:5,000) was bound for 1 h (27°C). Blots were
washed and reacted for 1 min with enhanced chemilumines-
cence reagent (Amersham) and exposed to x-ray film. The
fluorescent signal was quantitated by using a ChemiImager
(Alpha Innotech, San Leandro, CA).
Immunoelectron Microscopy. Samples were prepared for
electron microscopy using LR White as described by Hong et
al. (18). Sections were blocked with tris buffered saline (0.5%
Tween 20; 1% BSA) for 15 min, reacted with anti-PCNA
(1:200, 16 h, 4°C; Santa Cruz Biotechnology) and washed. The
bound antibody was detected by using gold-conjugated anti-
rabbit IgG (25 nm; Electron Microscopy Sciences, Ft. Wash-
ington, PA). Sections were stained with uranyl acetate (19) and
lead citrate (20) and visualized by using a Zeiss 10C transmis-
sion electron microscope (Texas A&M University Electron
Microscopy Center).
Purification of Virus. BV, ODV, and envelope and nucleo-
capsid fractions were purified as described in Braunagel and
Summers (2). The purity of the envelope and nucleocapsid
fractions was evaluated by using the antisera: BV:gp67, BVy
ODV-E26; ODV:ODV-E66, ODV-E56, and BVyODV-E26.
RESULTS
2EC27 Amino Acids Have Similarity with Cyclins and
2EC27 Is Part of a Complex Capable of Phosphorylating
Histone H1 and pRb in Vitro. The cyclin box is a highly
conserved feature among cellular and viral cyclins. 2EC27
shows an 18% overall similarity to cyclin B, while the region
between amino acids 80 and 110 shows 25–30% similarity to
the cyclin box of various cyclins (Fig. 1). Outside of the cyclin
box, cyclins also contain a conserved site for ubiquinitation
(‘‘destruction box’’; ref. 12) that is necessary for cyclin B
degradation and exit from mitosis. 2EC27 does not contain
such a destruction sequence (13).
To determine whether 2EC27 was part of an active kinase
complex, at the designated times postinfection (p.i.), Sf9 cell
lysates were immunoprecipitated by using 2EC27 antiserum,
and kinase activity of the precipitated complexes assayed by
using either histone H1 or pRb as in vitro substrate. Quanti-
tative analysis showed that the level of 2EC27-associated
histone H1 and pRb kinase activity increased by 18 h p.i.
reaching maximal levels of activity by 60 h p.i. (Fig. 2 A and B).
While pRb phosphorylation decreased slightly between 48–60
h p.i., repetitions of these experiments showed that the de-
crease was not significant. 2EC27 transcripts were detected by
16 h p.i. and protein detected by 18 h p.i.; thus the increase in
kinase activity was similar to the temporal expression of
2EC27 (Fig. 5A; ref. 13). We also noted that 2EC27 immu-
noprecipitated complexes from cell lysates between 6–18 h p.i.
have a low level of pRb-associated kinase activity. It may be
that 2EC27 antibody cross-reacts with a cellular protein, or
some activity is provided by input virus, but we have no
definitive explanation for this activity.
2EC27 Associates with Cdc2 and Cdk6. To identify the
serineythreonine kinase associated with 2EC27, we tested
selected cdks that are known to associate with cellular and viral
cyclins and form active kinase complexes (21). Infected cell
extracts (60 h p.i.) were incubated with antibodies to selected
cdks. Immune complexes were collected on protein AyG
agarose beads, separated by SDSyPAGE, and Western blot
analysis performed by using antiserum to 2EC27. 2EC27
coprecipitated with cdc2, suc1, cdk6 and to a lesser extent, cdk7
(Fig. 3).
To determine which of the cdk’s subunits were responsible
for kinase activity, lysates were prepared from infected cells
FIG. 1. Comparison of the cyclin box of 2EC27 (amino acids 80–110) with the cyclin box of cyclins. Shaded areas represent conservative amino
acids compared against the 2EC27 sequence. Rules for assignment of conservative amino acids are: G5A5S5T; V5L5I5M5F5Y5W; n 5
Q5D5E; r 5 K5H .
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(60 h p.i.) and immunodepleted for the individual kinase.
Immunodepletion removed '70–80% of the cdk proteins
(Fig. 4C, lanes 1 and 2; and data not shown). Kinase activity
of the 2EC27 immunoprecipitated complexes from these
depleted lysates was determined. 2EC27-associated histone
H1 kinase activity was reduced 50–60% when cell lysates were
depleted of cdc2 and reduced 30–40% when cdk6 was depleted
(Fig. 4 A and B, lanes 2 and 7). When both cdc2 and cdk6 were
depleted, kinase activity decreased 85–90% (Fig. 4 A and B,
lane 3). The removal of cdk2, cdk5, or cdk7 resulted in a
15–20% decrease in activity, while depletion of cdk4 showed
no significant change in kinase activity (Fig. 4 A and B, lanes
4–6, 8). Using pRb as in vitro substrate, depletion of cdk6
decreased 2EC27-associated kinase activity '50%, while
depletion of cdc2 reduced activity by 25% (Fig. 4B, lanes 2, 7).
When both cdc2 and cdk6 were depleted, 2EC27-associated
pRb kinase activity was reduced by 55% (Fig. 4B, lanes 4–6,
8). The residual activity of pRB phosphorylation after removal
of cdc2 and cdk6, could be caused by the presence of other,
unidentified protein(s) capable of interacting with 2EC27 to
form an active kinase. Removal of cdk7 caused minimal
effects. Depletion of cdk4 and cdk5 antibodies resulted in a
20–30% increase of 2EC27-associated pRb kinase activity
(Fig. 4B; lanes 4–6, 8). It is possible depletion of cdk4 and cdk5
resulted in removal of putative inhibitor(s) of 2EC27-
associated kinase activity. Finally, 2EC27 immunoprecipi-
tated complexes were separated by SDSyPAGE, and Western
blot analyses showed that the precipitated complex contained
cdc2 and cdk6 (Fig. 4C; lane 3). These data indicate that the
interaction with cdc2 and cdk6 can largely account for the
observed 2EC27-associated kinase activity.
PCNA Associates with 2EC27 and AcMNPV Nucleocapsids.
The data suggest that 2EC27 forms a functional complex with
cdk6, the catalytic subunit normally activated by D-type cyc-
lins. Cdk6-cyclin D complexes regulate cell cycle transition
from G1 to S phase and can bind PCNA. We speculated that
the cdk6-EC27 complex might also associate with PCNA. As
controls, cell lysates from various times p.i. were separated by
SDSyPAGE, and analyzed by Western blot analysis using
antibodies to 2EC27 or PCNA. 2EC27 was detected at 18 h
p.i., increased to higher levels by 24 h p.i. and remained at high,
steady-state levels throughout infection (Fig. 5A; a ODV-
EC27). PCNA was present in uninfected cell lysates (time 0)
and the total amount of PCNA decreased as infection pro-
gressed (Fig. 5A; a PCNA). To determine whether PCNA
associated with complexes containing 2EC27, complexes were
immunoprecipitated using antibody to 2EC27, separated by
using SDSyPAGE and analyzed by Western blot using anti-
FIG. 2. 2EC27-associated kinase activity. (A) Immunoprecipita-
tion using antibody to 2EC27 was performed from infected Sf9 cell
lysates at indicated times p.i. The kinase activity of the precipitated
complex was then assayed by using either histone H1 or pRb as the in
vitro substrate. (B) Phosphorylated histone H1 or pRb bands were
quantitated by using a PhosphorImager SF (Molecular Dynamics).
FIG. 3. Identification of protein kinases interacting with 2EC27.
Sf9 cell lysates were prepared at 60 h p.i. and used for immunopre-
cipitation with antibodies to cdc2, cdk2, -4, -5, -6, -7, and Suc1.
Immunoprecipitated complexes were separated by SDSyPAGE and
Western blot performed by using antisera to 2EC27.
FIG. 4. 2EC27 Association with Cdc2 and Cdk6 results in kinase
activity. (A) At 60 h p. i. Sf9 cell lysates were immunodepleted using
antibodies to indicated cdks. 2EC27 immunoprecipitated complexes
from these depleted lysates were obtained and then tested for kinase
activity by using either histone H1 or pRb as in vitro substrate. Samples
were separated by using SDSyPAGE, and phosphorylated bands of
histone H1 and pRb are shown. (B) Phosphorylated histone H1 and
pRb bands were quantitated by using a PhosphorImager SF (Molec-
ular Dynamics). These data were normalized, assigning the levels of
phosphorylation in undepleted lysates as 100%. (C) Lanes 1–2:
Comparing the levels of cdc2 and cdk6 in Sf9 cell lysates before and
after immunodepletion with cdc2 and cdk6 antibodies respectively.
Lane 3: At 60 h p.i. cell lysate was immunoprecipitated by using
2EC27 antibody and analyzed by Western blot by using antibody to
either cdc2 or cdk6.
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bodies to PCNA. The amount of PCNA detected in the 2EC27
immunoprecipitates increased as infection progressed and
roughly paralleled the increase in amount of 2EC27 (Fig. 5A;
ODV-EC27 IP; a PCNA). There were always detectable
amounts of PCNA in 2EC27 immunoprecipitated samples
from uninfected cells and early times p.i. It is possible that
2EC27 antibodies cross-react with a cellular protein that also
binds PCNA and this interaction could also account for the low
levels of pRb phosphorylation seen at early times p.i. (Fig. 2).
AcMNPV codes for a protein with homology to PCNA (22)
however, we do not know whether the cellular PCNA antibody
cross reacts with viral PCNA. Because 2EC27 was capable of
forming complexes with cdc2 and cdk6 (Fig. 3), we determined
which of these complexes was capable of binding PCNA. Cell
lysates (60 h p.i.) were immunoprecipitated using antibodies to
cdc2, suc1, or cdk6. The proteins were separated by SDSy
PAGE and analyzed by Western blot using antibodies to
PCNA (Fig. 5B). PCNA was detected only in the complex
containing cdk6 (Fig. 5B).
2EC27 is a structural protein of ODV (13). Association of
the cdk6-EC27 complex with PCNA suggested that PCNA
could also be a structural protein of the virus. AcMNPV BV
and ODV were purified, each separated into envelope (E) and
nucleocapsid (C) fractions (2), the proteins separated by
SDSyPAGE and analyzed by Western blot using antisera to
PCNA. PCNA was present in both BV and ODV and detected
only in the nucleocapsid fraction (Fig. 5B and data not shown).
The presence of PCNA within the viral nucleocapsid of ODV
was confirmed by using electron microscopy and ImmunoGold
labeling (Fig. 5C; arrows).
When AcMNPV-infected cell lysates were analyzed by West-
ern blot analysis using 2EC27 antibody, only one protein
product of 27 kDa was detected during the time course of
infection (Fig. 5A; a-ODV-EC27). 2EC27 was initially iden-
tified as a 27-kDa protein that was specific for ODV, however,
we noted that 2EC27 antibodies detected several higher
molecular mass bands in purified BV and ODV (Fig. 6A; ref.
13). The higher molecular mass proteins ('37, 61, and 90 kDa)
are only detected in purified virus. A series of SDSyPAGE
sample buffers (varying concentrations of SDS, DTT, temper-
ature, and times of treatment) were tested and all conditions
gave the same results (data not shown). Thus, if these higher
molecular weight proteins represent oligomeric forms of
2EC27, the oligomers are highly resistant to denaturation.
When comparing BV and ODV, the proteins in BV migrate at
a slightly higher molecular mass compared with ODV.
DISCUSSION
AcMNPV 2EC27 is the second viral-encoded cyclin homolog
to be reported (23–26). Two herpesviruses (Herpesvirus saimiri
and Karposi’s sarcoma-associated herpesvirus) code for a
FIG. 5. Association of PCNA with Cdk6–EC27 complex and
AcMNPV nucleocapsid. (A) Twenty-five micrograms of total protein
from infected Sf9 cell lysates (h p.i.) or 2EC27 immunoprecipitated
complex (ODV-EC27 IP) from 150 mg of whole-cell lysate (h p.i.) were
separated by using SDSyPAGE and analyzed by using Western blot
and antibodies to either 2EC27 (a-ODV-EC27) or PCNA (a-PCNA).
(B) Antibodies to Suc1, cdc2, and cdk6 were used to immunoprecipi-
tate the protein complex from Sf9 cell lysate (60 h p.i.). The proteins
were separated on SDSyPAGE gels and analyzed by Western blot by
using PCNA antibodies. Proteins of purified BV and ODV (20 mg)
were separated by using SDSyPAGE and analyzed by Western blot by
using PCNA antibodies. BV was fractionated into envelope (BV-E)
and nucleocapsid (BV-C) and preparations (10 mgysample) were
probed by using PCNA antibodies (a-PCNA). (C) ImmunoGold
localization of PCNA to nucleocapsid of ODV (arrows).
FIG. 6. 2EC27 immunoreactive proteins of BV and ODV and
model of interaction of 2EC27 with Cdc2, Cdk6 and PCNA. (A)
Purified BV and ODV were separated by using SDSyPAGE and
analyzed by Western blot using 2EC27 antibodies. The 27-kDa form
is unique to ODV (this data is reproduced from ref. 13). (B) 2EC27
can associate with either cdc2 (cyclin B-like activity) or cdk6 (cyclin
D-like activity). The cdk62EC27 complex is also capable of binding to
PCNA. Protein ‘‘?’’ represents other potential, currently unknown
partners.
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homolog to cyclin D. The herpesvirus cyclin associates with
cdk6 (23–25) and catalyzes in vitro phosphorylation of histone
H1 and pRb (26). The complex may be resistant to inhibition
by the cdk inhibitors, p21Cip1, p27Kip1 and p16Ink-4a. Expression
of the herpesvirus cyclin prevents G1 arrest imposed by each
inhibitor and stimulates cell cycle progression in quiescent
fibroblasts (23, 25). Thus, the herpesvirus cyclin-kinase com-
plexes are able to mediate progression of events through cell
cycle checkpoints (26).
The baculovirus cyclin, 2EC27 has distinct functional char-
acteristics compared to cellular and viral cyclins. Depending
on the cdk protein, and perhaps other viral or cellular proteins
yet to be described, the kinase-EC27 complex may have either
cyclin B- or D-like activity (Fig. 6B). Thus two models of
2EC27 cyclin-like activities can be considered.
Cyclin B-like Function. Baculovirus infection results in an
enlarged cell and nucleus, increased fluidity of an intact
nuclear envelope, induction of microvesicles and membranes
in the nucleoplasm, and arrest of the host cell in G2yM phase
with sustained cdc2-associated histone H1 kinase activity (3).
A functional cyclin B-like kinase (cdc2-EC27) could partially
explain these major phenotypic characteristics. Cellular cyclin
B-cdc2 function is key in the progression of the cell from G2
to M phase. The complex accumulates in the nucleus, is
activated by cdc25, and phosphorylates nuclear lamins. Phos-
phorylation results in breakdown of the nuclear lamina and
increased nuclear envelope fluidity. Cyclin B is then degraded
and, concomitant with cyclin B destruction, the cell progresses
to anaphase with fenestration andyor dispersal of the nuclear
envelope. If cyclin B is not degraded, cells are arrested at
mid-metaphase with an intact nuclear envelope (8–12). Using
antibodies to cyclin B, we previously reported that cellular
cyclin B levels accumulate at the time of baculovirus G2yM
arrest and are then rapidly degraded (3). This data suggest that
the cellular cdc2-cyclin B complex was active and had likely
phosphorylated and dispersed the nuclear lamins, thus releas-
ing nucleoskeleton structural constraints on the infected cell
nuclear envelope. The identification of a viral cyclin capable of
cyclin B-like activity suggests that after the degradation of
cellular cyclin B, certain structural and functional dynamics of
the nuclear envelope can be maintained by the active cdc2-
EC27 complex. Such a model would predict increased fluidity
of the nuclear envelope to allow the production of intranuclear
microvesicles, which begin to accumulate at the time of G2yM
arrest and are precursors to the ODV envelope. However, our
previous data showed that formation of protein-rich intranu-
clear vesicle structures can accumulate within the nucleoplasm
even when infected cells are arrested at G1yS phase (3). Thus,
it is likely that cdc2-EC27 activity is not the only factor(s) that
function to maintain nuclear envelope fluidity for the virus-
induced processes responsible for the formation of intranu-
clear microvesicles and viral envelopes.
The selective advantage(s) for AcMNPV to arrest the host
cell cycle at G2yM phase may not be restricted to changes in
the dynamics of the nuclear envelope and maturation of ODV.
Infection with HIV-1 results in host cell cycle arrest at G2yM
phase. At this phase viral gene transcription is optimized at the
expense of host (cellular) gene transcription. It was suggested
that one advantage of maintaining the host cell cycle in G2yM
phase could be to optimize virus production through regulat-
ing viral gene transcription (27). Although the Sf9 cell cycle-
dependent rate of AcMNPV transcription has not been stud-
ied, it was shown that there is a significant reduction in host cell
RNA and protein synthesis between 12 and 18 h p.i. (28). This
time frame correlates well with the time of AcMNPV induced
Sf9 cell cycle arrest at G2yM phase (3).
Cyclin D-like Function. AcMNPV must have the capacity to
influence or regulate cellular vs. viral DNA replication. Using
transfection techniques, Prikhod’ko and Miller (29) showed
that the viral; ie22 gene product was sufficient to arrest Sf9
cells in S phase. The arrested cells did not undergo mitosis, had
abnormally large nuclei and contained greater than 4N DNA
content. In contrast, results from viral infection show cells are
arrested at G2yM phase, with no detectable increase in cellular
DNA content (3). Thus, during viral infection cellular DNA
replication is not detectable, while viral DNA replication
occurs at a rapid rate. Surprisingly, even after infected cells
were arrested at G2yM phase, viral DNA replication continues
that suggest that AcMNPV could code for protein(s) capable
of ‘‘over-riding’’ those cell cycle checkpoints. A cdk6-EC27
complex resulting in cyclin D-like activity may partially explain
continuing viral DNA replication during G2yM phase arrest.
Cyclin D1 associates with four different kinases (cdk2, cdk4,
cdk5, and cdk6), PCNA, and the inhibitor p21 (30, 31). The
binding and phosphorylation of pRb by cdk-cyclin D promotes
the transition from G1 to S phase (32, 33). In addition,
cdk-cyclin complexes can ‘‘titrate’’ cdk inhibitors such as
kinase inhibitory protein-1 (p27Kip1) into ternary complexes
resulting in activation of the cdk2-cyclin E complex (34).
Cdk2-cyclin E can then affect components of preinitiation
complexes to trigger DNA replication (35). Thus, the presence
of an active cdk6-EC27 complex (cyclin D-like activity) could
result in maintaining an active replication complex even when
cells are outside of S phase. Other viruses (human papilloma-
virus, adenovirus, and others) depend on the host cell entry
into S phase to replicate their viral DNA, and have developed
various mechanisms to establish an S phase environment (for
review; see ref. 36), and infection with human cytomegalovirus
stimulates replication of only viral DNA (37).
PCNA, an auxiliary factor for DNA polymerases b and g, is
essential for eukaryotic DNA replication and repair (38).
Mammalian cells contain soluble (free) and insoluble (chro-
matin-bound) populations of PCNA, and the bound state of
PCNA is regulated by the cell cycle (39, 40). The regulated
distribution of PCNA from the soluble to insoluble form can
function in G2yM arrest presumably by modifying the assem-
bly, stoichiometry andyor subcellular targeting of the cyclin-
cdk-p21-PCNA quaternary complex (41, 42, 43). AcMNPV
encodes a homolog of PCNA [vPCNA; refs. 22 and 28] and
while an obvious function of vPCNA would be as an accessory
factor for viral DNA polymerase, a role of vPCNA in viral
DNA replication has not been observed (44). Cells infected
with a recombinant virus where the C terminus of the vPCNA
gene was deleted, exhibited a slight delay in late gene expres-
sion (45). PCNA may not be an essential gene for baculoviruses
because a PCNA homolog has not been identified in the
genome of Bombyx mori NPV (46).
Because both 2EC27 and PCNA are structural proteins of
ODV and would be presented to the gut cells of the insect
immediately upon infection, another function for this protein
complex is possible. The columnar cells of the gut are differ-
entiated cells (noncycling) and are a site of primary infection.
It may be that the presentation of 2EC27, PCNA and perhaps
other viral structural proteins, along with the expression of
immediate early genes, establishes an “S phase-like” environ-
ment in these cells. This environment then facilitates viral
DNA replication. PCNA is also detected in purified BV;
however, the 27-kDa form of 2EC27, which is always associ-
ated with active kinase complexes, is not detected. BV contains
2EC27 immunoreactive bands at higher molecular masses.
This suggests that the 2EC27 immunoreactive forms may be
differentially processed or stably complexed with itself or other
proteins in BV (Fig. 6A; ref. 13). If so, it is possible that these
“complexed” forms of 2EC27 may also function to promote an
S phase-like environment when BV infects secondary tissues,
some of which are also differentiated cells (i.e., fat body). In
addition to the 27-kDa form, ODV also contains higher
molecular mass, immunoreactive forms of 2EC27. Thus, the
composition and function(s) of the 2EC27 complex may
be more complicated than the simple model presented
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here. The process of infection by either BV or ODV clearly can
introduce these proteins into host cells and may provide
AcMNPV with the ability to redirect the host cellular processes
to benefit virus infection.
Other AcMNPV Gene Products that May Function in Cell
Cycle Regulation. While it is not known whether baculovirus-
encoded kinases andyor phosphatases function in virus-
induced cell cycle arrest, we note that AcMNPV codes for two
protein kinases, a protein kinase-interacting protein, and at
least one protein phosphatase (47–51). The baculovirus pk-1
gene encodes a serine-threonine kinase catalytic subunit that
is capable of phosphorylating histone H1. Pk-1 is first detected
at 12 h p.i. and accumulates to high levels during the late phase
of infection (50), and protein kinase activity is associated with
both BV and ODV (52). It will be of interest to see whether
any of these proteins interact with 2EC27 and whether they
function in virus-induced cell cycle arrest or viral DNA
replication.
The results from this study show that AcMNPV encodes a
multifunctional cyclin. Depending on its kinase partner
2EC27 may either: (i) associate with cdc2 kinase and provide
an undegradable analog of cdc2-B cyclin complex or (ii)
associate with cdk6 and provide cyclin D-like activity. The
significance of the cdk6-EC27-PCNA complex is unknown;
however, we note that PCNA is a component of both BV and
ODV. The apparent multifunctional roles of 2EC27 may
include arrest of the host cell cycle at G2yM phase, or
regulation of viral andyor cellular DNA replication.
Baculovirus Expression Vector System. The polyhedrin and
p10 gene promoters are widely used for protein expression and
are maximally active during the late and very late phases of
infection, times when the infected cells are arrested in G2yM
phase. Thus, foreign genes expressed under the control of
these promoters are expressed in a G2yM phase environment.
The additional observation that baculovirus codes for it own
unique multifunctional cyclin has special implications for
studies where cell cycle regulated products (cyclins, cdks, etc.)
are being expressed. These proteins may have modifications
unique to baculovirus or G2yM phase arrest.
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